Cardiology News / Recent Literature Review / Second Quarter 2020
Cardiology News
Abstract
Cardiology News / Recent Literature Review / Second Quarter 2020
Rhythmos 2020;15(3):55-63.
ESC Meeting/Digital Experience: 29/8-1/9/2020
TCT/ Virtual Event: 14-18/10/2020
HCS/Panhellenic (41st) Congress of Cardiology: Athens, 22-24/10/2020
AHA Meeting 2020: cancelled
ACC Meeting: Atlanta, 20-22/3/2021
EHRA Meeting: Barcelona, 28-30/3/2021
Women Have a Higher Risk of MACE and Ischemia-Driven Target Lesion Revascularization (ID-TLR) Compared With Men at 5 Years Post-PCI
Among 32,877 patients, 9,141 (27.8%) were women who were older and had higher body mass index, more frequent hypertension and diabetes, and less frequent history of surgical or percutaneous revascularization compared with men. Lesions in women had smaller reference vessel diameter and shorter lesion length. At 5 years, women had a higher rate of MACE (18.9% vs 17.7%; p=0.003), all-cause death (10.4% vs 8.7%; p=0.0008), cardiac death (4.9% vs 4.0%; p=0.003) and ID-TLR (10.9% vs 10.2%; p=0.02) compared with men. By multivariable analysis, female sex was an independent predictor of MACE (hazard ratio [HR:]: 1.14; p=0.04) and ID-TLR (HR: 1.23; p=0.009) but not all-cause death (HR: 0.91; p=0.30) or cardiac death (HR: 0.97; p=0.85) (Kosmidou I et al, J Am Coll Cardiol 2020; 75:1631-40).
PARAGON-HF: Baseline and Mean Achieved Systolic Blood Pressure (SBP) of 120-129 mmHg Identified the Lowest Risk Patients With Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/ Valsartan
Among 4,795 trial participants (age 73 ± 8 years, 52% women), multivariable analysis indicated that baseline and mean achieved SBP of 120-129 mmHg demonstrated the lowest risk for all outcomes. Sacubitril/valsartan reduced SBP by 5.2 mmHg compared with valsartan at 4 weeks, which was not modified by baseline SBP. However, sacubitril/valsartan reduced SBP more in women (6.3 mmHg) than men (4 mmHg) (interaction p=0.005). Change in SBP was directly associated with change in NT-proBNP (p<0.001) but not symptom score (p=0.40) (Selvaraj S et al, J Am Coll Cardiol 2020; 75:1644-56)... (excerpt)
Downloads
Downloads
Published
Versions
- 2020-07-15 (2)
- 2020-07-15 (1)
Issue
Section
License
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
